title: Sexual dysfunction following radical prostatectomy.
abstract: Prostate cancer is the most common solid cancer in men and the second  leading cause of cancer death in men. A favored treatment option for  organ-confined prostate cancer in a middle-aged healthy man is radical  prostatectomy (RP). Despite advances in techniques for RP, there remain  concerns among physicians and patients alike on its adverse effects on sexual  function. Although post-RP erectile dysfunction has been extensively studied,  little attention has been focused on the other domains of sexual function,  namely loss of libido, ejaculatory dysfunction, orgasmic dysfunction, penile  shortening, and Peyronie disease. The aim of this review is to discuss the  most recent literature regarding post-RP sexual dysfunctions.
authors: Department of Urology, Louisiana State University, New Orleans, Louisiana 70112, USA.
authors: Cooper R
authors: CR
authors: Benson
authors: Ege Can
authors: EC
authors: Serefoglu
authors: Wayne J G
authors: WJ
authors: Hellstrom
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use; D000818:Animals; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D007989:Libido; D008297:Male; D008875:Middle Aged; D010411:Penile Induration / Q000209:etiology; D010413:Penis / Q000187:drug effects / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use; D011468:Prostatectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000601:surgery*; D011687:Purines / Q000627:therapeutic use; D011788:Quality of Life; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy / Q000209:etiology*; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D000527:Alprostadil